Pest and disease incursions can impose significant costs of forgone production and trade. Additionally, there are costs of management activities such as hazard reduction, eradication and control. The assessment of these costs and the determination of the optimal management response have attracted attention in recent years. Minimising the expected present value of the total of the above mentioned costs is one of the criteria for determining how to protect the economy from the effects of unmitigated hazards. It involves a tradeoff between additional expenditure on management activities such as hazard reduction and their expected benefits such as a reduced hazard rate of future incursions. In this paper, an analytical expression is developed for the expected discounted present value of all future incursion and management costs for the case of recurrent episodes of pest or disease incursion and eradication where there is uncertainty about the arrival of disease incursions and about the outcome of the eradication process. Uncertainty about the outcome of the eradication process means that it is uncertain whether the pest or disease is completely removed at the end of the eradication process. The optimal expenditure on management activities for a risk-neutral decision maker is obtained by minimising the derived expression with respect to the levels of management activities, subject to the relationships between management activities and their associated outcomes such as a reduction of the hazard rate. An example is provided to illustrate the determination of the combination of management activities that minimises the expected economic cost of pest or disease incursions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.